Retinal anti-angiogenesis by a new route

Roy Bicknell

doi:10.1038/nbt0508-528

Retinal anti-angiogenesis by a new route

Roy Bicknell

Immunology and Immunotherapy

Research output: Contribution to journal › Article

1 Citation (Scopus)

Abstract

A regulator of VEGF signaling shows therapeutic potential for retinal disease.

Original language	English
Pages (from-to)	528-529
Number of pages	2
Journal	Nature Biotechnology
Volume	26
Issue number	5
DOIs	https://doi.org/10.1038/nbt0508-528
Publication status	Published - 1 May 2008

Access to Document

10.1038/nbt0508-528

Cite this

@article{2bd70739a2c44f558abfd9d53756ce7c,

title = "Retinal anti-angiogenesis by a new route",

abstract = "A regulator of VEGF signaling shows therapeutic potential for retinal disease.",

author = "Roy Bicknell",

year = "2008",

month = may,

day = "1",

doi = "10.1038/nbt0508-528",

language = "English",

volume = "26",

pages = "528--529",

journal = "Nature Biotechnology",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Retinal anti-angiogenesis by a new route

AU - Bicknell, Roy

PY - 2008/5/1

Y1 - 2008/5/1

N2 - A regulator of VEGF signaling shows therapeutic potential for retinal disease.

AB - A regulator of VEGF signaling shows therapeutic potential for retinal disease.

U2 - 10.1038/nbt0508-528

DO - 10.1038/nbt0508-528

M3 - Article

C2 - 18464784

VL - 26

SP - 528

EP - 529

JO - Nature Biotechnology

JF - Nature Biotechnology

IS - 5

ER -

Retinal anti-angiogenesis by a new route

Abstract

Access to Document

Fingerprint

Cite this